High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

Simple item page
dc.contributor.authorGupta, Ravindra K.
dc.contributor.authorRanopa, Michael
dc.contributor.authorKityo, Cissy
dc.contributor.authorLyagoba, Fred
dc.contributor.authorMugarura,Lincoln
dc.contributor.authorKaleebu, Pontiano
dc.date.accessioned2025-01-19T18:07:08Z
dc.date.available2025-01-19T18:07:08Z
dc.date.issued2013-12-18
dc.description.abstractIn a randomized comparison of nevirapine or abacavir with zidovudine plus lamivudine, routine viral load monitoring was not performed, yet 27% of individuals with viral failure at week 48 experienced resuppression by week 96 without switching. This supports World Health Organization recommendations that suspected viral failure should trigger adherence counseling and repeat measurement before a treatment switch is considered.
dc.identifier.citationGupta, R. K., Goodall, R. L., Ranopa, M., Kityo, C., Munderi, P., Lyagoba, F., ... & Dunn, D. (2014). High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy. Clinical infectious diseases, 58(7), 1023-1026.https://doi.org/10.1093/cid/cit933
dc.identifier.issn1537-6591
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/9796
dc.language.isoen
dc.publisherClinical infectious diseases
dc.titleHigh Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
cit933.pdf
Size:
133.85 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences